期刊文献+

分子伴侣Tapasin在介导特异性细胞毒性T淋巴细胞反应中的作用 被引量:2

The role of the endoplasmic reticulum chaperone tapasin in mediating specific CTL responses
下载PDF
导出
摘要 病毒及肿瘤细胞的清除很大程度上依赖于特异性CD8+细胞毒性T淋巴细胞(CTL),CTL通过T细胞受体(TCR)特异性识别病毒肽段并通过MHC-I类分子提呈引起感染细胞融解,经典MHC-I类分子在内质网内的装配要求有抗原肽配体和β2微球蛋白(β2m)的存在,而这一过程需要伴侣分子(chaperones)如Tapasin的参与。Tapasin是抗原递呈相关转运体(TAP)相关蛋白的基因产物,与MHC-I类分子同为免疫球蛋白超家族成员,在介导特异性CTL反应中有着重要作用,本文简述了Tapasin分子结构特征、在介导特异性CTL反应中的作用及与疾病的联系。 The clearing of virus and tumor cell a large degree relied on Specific CD8 + cyto- toxic T lymphocytes (cytotoxie T cell, CTL). CTL recognised virus peptide paragraph through T cell receptor (TCR) and caused infection cell melting through MHC-I class molecular presen- ting. The assembly of classic MHC-I molecular composition in endoplasmic reticulum (ER) re- quired antigen peptide ligand and beta 2m, and this process need chaperones such as tapasin. Tapasin was offspring of transporters associated with antigen processing (TAP) and a member of the immunoglobulin superfamily as well as MHC-I. Tapasin as molecular bridges between TAP and MHC-I, have an important role in me- diated specific CTL reactions. This review re- sumes its biological characteristics, the role in mediated specific CTL reactions and contacting with diseases.
出处 《中国临床药理学与治疗学》 CAS CSCD 2013年第2期212-216,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金项目(31000414)
关键词 TAPASIN 细胞毒性T淋巴细胞 MHC-I类分子 抗原加工 Tapasin Cytotoxic T cell MHC-I Antigen processing
  • 相关文献

参考文献29

  • 1Tey SK, Khanna R. Host immune system strikes back., autophagy-mediated antigen presentation by- passes viral blockade of the classic MHC class I processing pathway [J]. Autophagy, 2012, 8(12): 1-3.
  • 2赵亮,范丽安.Tapasin对HLA-E细胞表面表达的影响[J].中国免疫学杂志,2002,18(2):82-84. 被引量:2
  • 3Antoniou AN, Powis SJ, Elliott T. Assembly and export of MHC class I peptide ligands [J]. Curr Opin Immunol, 2003, 15(1): 75-81.
  • 4Sadegh-Nasseri S, Chen M, Narayan K, et al. The convergent roles of tapasin and HLA-DM in antigen presentation [J].Trends Immunol, 2008, 29(3) 141-147.
  • 5Crbrera CM. The double role of the endoplasmie re- ticulum chaperone tapasin in peptide optimization of HLA class I molecules [J]. Stand J Immunol, 2007, 65(6): 487-493.
  • 6Wilson M J, Torkar M, Trowsdale J. Genomic or- ganization of a human killer cell inhibitory receptor gene [J]. Tissue Antigens, 1997, 49 (6): 574- 579.
  • 7Herberg JA, Sgouros J, Jones T, et al. Genomic a- nalysis of the tapasin gene, located close to the TAP loci in the MHC [J]. Eur J Immunol, 1998, 28(2) : 459-467.
  • 8Chapman DC, Williams DB. ER quality control in the biogenesis of MHC class I molecules [J]. Semin Cell Dev Biol, 2010, 21(5): 512-519.
  • 9Howarth M, Williams A, Tolstrup AB, et al. Tapasin enhances MHC class I peptide presentation according to peptide half-life [J].Proc Natl Acad Sci USA, 2004, 101(32): 11737-11742.
  • 10Lu X, Kavanagh DG, Hill AB. Cellular and molec- ular requirements for association of the murine cyto- megalovirus protein m4/gp34 with major histocom- patibility complex class I molecules[J]. J Virol, 2006, 80(12): 6048-6055.

二级参考文献33

  • 1Tong-DongShi,Yu-ZhangWu,Zheng-CaiJia,Li-YunZou,WeiZhou.Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD_8^+ CTL-mediated cytotoxicity in HLA-A2^+ human PBMCs[J].World Journal of Gastroenterology,2004,10(13):1902-1906. 被引量:13
  • 2Frederck M 颜子颖等(译).精编分子生物学实验指南[M].北京:科学出版社,1998.6.
  • 3Wang Z, Hu Q, Han W, et al. Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro [J]. Int J Oral Maxillofac Surg, 2006, 35 (6) : 544-50.
  • 4Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen downregulation in human cancers: T-- cell immunotherapy revives an old story [J]. Mol Med Today, 1999, 5(4) : 178 -186.
  • 5Garcia--Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape [J]. J Cell Physiol, 2003, 195(3): 346--355.
  • 6Reiman JM, Kmieciak M, Manjili MH, et al. Tumor immunoediting and immunosculpting pathways to cancer progression [J]. Semin Cancer Biol, 2007, 17(4): 275--287.
  • 7Lou Y, Basha G, Seipp RP, et al. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor--free survival [J]. Clin Cancer Res, 2008, 14(5) : 1494--1501.
  • 8Garbi N, Tiwari N, Momburg F, et al. A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression [J]. Eur J Immunol, 2003, 33(1) : 264--73.
  • 9Seliger B, Atkins D, Bock M, et aI. Characterization of human lymphocyte antigen class I antigen--processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter--associated with antigen-processing down --regulation [J]. Clin Cancer Res, 2003, 9(5) : 1721-7.
  • 10Matsui M, Ikeda M, Akatsuka T. High expression of HLA -- A2 on an oral squamous cell carcinoma with down-- regulated transporter for antigen presentation [J]. Biochem Biophys Res Commun, 2001, 280(4) : 1008--14.

共引文献9

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部